GOSS Insider Trading

Insider Ownership Percentage: 5.00%
Insider Buying (Last 12 Months): $249,240.00
Insider Selling (Last 12 Months): $1,259.28

Gossamer Bio Insider Trading History Chart

This chart shows the insider buying and selling history at Gossamer Bio by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$1M-$500k$0$500k$1MTotal Insider BuyingTotal Insider Selling

Gossamer Bio Share Price & Price History

Current Price: $1.00
Price Change: Price Decrease of -0.1 (-9.09%)
As of 04/1/2025 04:03 PM ET

This chart shows the closing price history over time for GOSS up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMar$1.10Closing price on 03/31/25:

SEC Filings (Institutional Ownership Changes) for Gossamer Bio (NASDAQ:GOSS)

81.23% of Gossamer Bio stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at GOSS by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$17Mbought$8.38MsoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$20M$0$20MTotal InflowsTotal Outflows
Gossamer Bio logo
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary arterial hypertension (PAH) in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony-stimulatin factor 1 receptor and c-KIT inhibitor, which is in Phase 3 clinical trial for the treatment of PAH. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. Gossamer Bio, Inc. was incorporated in 2015 and is headquartered in San Diego, California.
Read More on Gossamer Bio

Today's Range

Now: $1.00
Low: $0.99
High: $1.15

50 Day Range

MA: $1.20
Low: $0.89
High: $1.53

52 Week Range

Now: $1.00
Low: $0.50
High: $1.55

Volume

1,560,963 shs

Average Volume

1,565,927 shs

Market Capitalization

$227.22 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.86

Who are the company insiders with the largest holdings of Gossamer Bio?

Gossamer Bio's top insider investors include:
  1. Faheem Hasnain (CEO)
  2. Bryan Giraudo (CFO)
  3. Richard Aranda (Insider)
Learn More about top insider investors at Gossamer Bio.